Rare diseases
Investigational molecules
Locations
Back to Germany18 clinical trials in Flensburg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A Study of Pembrolizumab and Radiotherapy for Patients with Early-Stage Favorable Classic Hodgkin Lymphoma
GermanyA study testing tenecteplase given directly into the artery after blood clot removal in patients with acute ischemic stroke in the front part of the brain
GermanyGermanyStudy of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
GermanyStudy on Ivosidenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy
GermanyStudy on Revumenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy
GermanyStudy of Iberdomide and Isatuximab for Maintenance Therapy in Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation
GermanyStudy on Preventing Kidney Problems in Peripheral Arterial Disease Patients Using Carbon Dioxide and Iopamidol, Iomeprol, and Iopromide During Vascular Procedures
GermanyTesting Tarlatamab in Patients with Advanced Small-Cell Lung Cancer Who Have Poor Physical Condition
GermanyStudy Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation
GermanyStudy of luspatercept in patients with low-risk myelodysplastic syndrome (MDS) who do not require blood transfusions and have not received erythropoiesis treatment
GermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on Acute Myeloid Leukemia (AML) and novel combination therapies. Studies evaluating targeted treatments for patients with specific genetic mutations and those ineligible for intensive chemotherapy.
Multiple innovative approaches being tested to improve survival rates and treatment outcomes.
Clinical trials examining new treatments for lung cancer and colorectal cancer, with a focus on targeted therapies and personalized medicine approaches.
Studies incorporating biomarker testing and molecular diagnostics for treatment selection.
Research initiatives exploring quality of life improvements for cancer patients, including innovative symptom management approaches.
Focus on developing evidence-based supportive care strategies for oncology patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
